BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Drug Companies Abbott Laboratories (ABT), B. Braun Medical Ltd. and Roxane Laboratories, Inc., Paying $421 Million to Settle Government Case


12/7/2010 12:04:57 PM

WASHINGTON (Dow Jones)--Three U.S. drug makers and their affiliates have agreed to settle federal charges that they engaged in a scheme to report inflated drug prices to get higher reimbursements from government medical care programs, the U.S. Department of Justice said Tuesday. Abbott Laboratories Inc. (ABT), B. Braun Medical Inc., Roxane Laboratories Inc. and affiliated entities have agreed to pay $421 million to settle the charges, the Justice Department said.

Read at News Release
Read at ABC News
Read at Bloomberg
Read at Wall Street Journal

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES